The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of entinostat (Ent), atezolizumab (A), carboplatin (C), and etoposide (E) in previously untreated extensive-stage small cell lung cancer (ES-SCLC), ETCTN 10399.
 
Ryan D. Gentzler
Honoraria - Targeted Oncology
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Daiichi Sankyo/Astra Zeneca; Jazz Pharmaceuticals; Mirati Therapeutics; OncoCyte; Sanofi
Research Funding - Bristol-Myers Squibb; Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Helsinn Therapeutics (Inst); Janssen (Inst); Jounce Therapeutics (Inst); Merck (Inst); Mirati Therapeutics (Inst); Pfizer (Inst); RTI International (Inst); Takeda (Inst)
 
Richard Piekarz
No Relationships to Disclose
 
Liza C Villaruz
Consulting or Advisory Role - Achilles Therapeutics; Bristol-Myers Squibb/Celgene; Daiichi Sankyo/Astra Zeneca; Janssen Oncology; Jazz Pharmaceuticals; Takeda
Research Funding - AstraZeneca (Inst); BioAtla (Inst); Black Diamond Therapeutics (Inst); BMS (Inst); Celgene (Inst); Exelixis (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Lilly (Inst); Merck (Inst); Rain Therapeutics (Inst); Regeneron (Inst)
 
John C. Rhee
No Relationships to Disclose
 
Wei-Chu Victoria Lai
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca/MedImmune; G1 Therapeutics; Jazz Pharmaceuticals; Merck
Research Funding - AbbVie (Inst); Amgen (Inst); BMS (Inst); Daiichi Sankyo (Inst); Merck (Inst)
 
Bethany Horton
Research Funding - Merck (Inst)
 
Joseph Mock
No Relationships to Disclose
 
Michael Hanley
No Relationships to Disclose
 
Michelle A. Rudek
Employment - GlaxoSmithKline (I)
Leadership - American Society for Clinical Pharmacology & Therapeutics; Geminus Therapetuics
Stock and Other Ownership Interests - Geminus Therapetuics
Consulting or Advisory Role - Leidos
Research Funding - Cullinan Oncology (Inst); RenovoRx (Inst)
Other Relationship - British Pharmacological Society; CMTx Biotech, Inc.; UpToDate
 
Mitch A. Phelps
No Relationships to Disclose
 
Michael Anthony Carducci
Consulting or Advisory Role - Exelixis; Foundation Medicine; Pfizer; Roche/Genentech
Research Funding - Arcus Biosciences (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); pfizer (Inst)
 
Charles M. Rudin
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bridge Medicines; Daiichi Sankyo/UCB Japan; Earli; Epizyme; Genentech/Roche; Harpoon Therapeutics; Ipsen; Jazz Pharmaceuticals; Kowa; Merck; Syros Pharmaceuticals; Syros Pharmaceuticals
Research Funding - Merck (Inst); Roche/Genentech (Inst)